Description
AGENDA
Cambridge Biosafety Committee
Thursday, April 27th, 2017 – 3:00 pm
119 Windsor Street
Introductions
Presentations
- Casebia Therapeutics (Michael Bruce) will present a request for a new BSL-1/BSL-2 permit for their facility at 610 Main Street, 5th Floor.
- Arbor Biotechnologies (David Scott/Winston Yan) will present a request for a new BSL-1/BSL2 permit for their facility at 790 Memorial Drive.
- Cellaria (Philip Manos) will present a request for a new BSL-1/BSL-2 permit for their facility at 675 West Kendall Street (Mass Innovations Lab)
- The Engine/ LabCentral (Mark Rosenshein, Celina Chang)will present a request for a new BSL-1/BSL-2 permit for their facility at 501 Massachusetts Avenue
Old Business/Site visits
3/21 – Constellation (11 Hurley Street) amendment walkthrough – BSL-1/BSL-2
3/22 – Merck Research Labs (320 Bent Street) new permit walkthrough – BSL-2 ONLY
3/28 – KSQ (610 Main Street) amendment walkthrough - BSL-2 ONLY
3/30 – InVivo Therapeutics (One Kendal Square Bldg 1400E) - BSL-1/BSL-2
4/11 – Bicycle Therapeutics (200 CambridgePark Drive) new permit - BSL-2 ONLY
4/12 – Bluebird Bio (60 Binney Street) – amendment walkthrough - BSL-1/BSL-2
4/13 – Omega Therapeutics (215 First Street, 4th Floor) new permit - BSL-1/BSL-2
4/19 – Inari Agriculture/VL37/VL43 (200 Sidney Street, 3rd Floor) - BSL-1/BSL-2
New Business
- Review of requirement for negative air in BSL-2 with respect to non-BSL-2 areas
InVivo Therapeutics requests waiver for lab in older facility.
- Cambridge Biosafety Forum: May 10th & 16th, 5:00-8:00 pm, Macht Auditorium
Adjourn